DAPARION-10
Dapagliflozin Tablets 10 mg
For Sugar Control with Cardio-Renal Protection
Diabetes – A Growing Burden in India
- Over 100 million Indians live with diabetes (ICMR 2023)
- Cardiovascular & renal complications are leading causes of morbidity
- Early intervention is crucial for long-term protection
Mechanism of Action
- Inhibits SGLT2 in proximal renal tubules
- Promotes urinary glucose excretion
- Reduces blood glucose, blood pressure & body weight
Daparion-10 – Triple Protection
- Glycemic control (↓ HbA1c ~0.7%)
- Renal protection
- Cardiovascular protection
- Weight & BP reduction
Dosing & Administration
- 10 mg once daily
- Can be taken with or without food
- No dose adjustment required for mild/moderate renal impairment
DAPARION-M500
Dapagliflozin 10 mg & Metformin HCl 500 mg (SR) Tablets
Dual Action Therapy for Effective Glycemic Control
Dapagliflozin
- Increases glucose excretion through urine
- Improves fasting (FFG) & post-prandial plasma glucose
- Effective in patients with Type-2 Diabetes Mellitus
Metformin
- First-line drug for the treatment of Type-2 diabetes
- Reduces hepatic glucose production
- Improves insulin sensitivity
Combination Benefits
- Additional reduction in blood glucose concentration
- Supports moderate weight loss
- Helps reduce systolic blood pressure
Dosing & Administration
- Once daily or as directed by physician
- Preferably taken with meals
- Suitable for long-term diabetes management
Daparion Trio-500
Dapagliflozin 10 mg, Sitagliptin 100 mg & Metformin Hydrochloride (ER) 500 / 1000 mg Tablets
For Comprehensive Management of Type-2 Diabetes Mellitus
The Growing Challenge of Diabetes
- Over 100 million diabetic patients in India (ICMR 2023)
- Progressive β-cell decline leads to therapy failure
- Triple therapy helps achieve durable glycemic control
Rationale for Triple Combination
- Targets 3 key mechanisms of hyperglycemia
- SGLT2 inhibition – Dapagliflozin
- DPP-4 inhibition – Sitagliptin
- Reduced hepatic glucose output – Metformin
Clinical Benefits
- Superior HbA1c reduction vs mono & dual therapy
- Improved fasting & post-prandial glucose control
- Weight neutrality or modest weight reduction
- Cardio-renal protective benefits
Dosing & Administration
- Once daily or as prescribed by physician
- Preferably taken with meals
- Available in 500 mg & 1000 mg Metformin strengths
Daparion Trio-1000
Dapagliflozin 10 mg, Sitagliptin 100 mg & Metformin Hydrochloride (ER) 500 / 1000 mg Tablets
For Comprehensive Management of Type-2 Diabetes Mellitus
The Growing Challenge of Diabetes
- Over 100 million diabetic patients in India (ICMR 2023)
- Progressive β-cell decline leads to therapy failure
- Triple therapy helps achieve durable glycemic control
Rationale for Triple Combination
- Targets 3 key mechanisms of hyperglycemia
- SGLT2 inhibition – Dapagliflozin
- DPP-4 inhibition – Sitagliptin
- Reduced hepatic glucose output – Metformin
Clinical Benefits
- Superior HbA1c reduction vs mono & dual therapy
- Improved fasting & post-prandial glucose control
- Weight neutrality or modest weight reduction
- Cardio-renal protective benefits
Dosing & Administration
- Once daily or as prescribed by physician
- Preferably taken with meals
- Available in 500 mg & 1000 mg Metformin strengths
Sitasaur M 50/500
Sitagliptin Phosphate 50 mg & Metformin Hydrochloride 500 mg Tablets
Strong Glycemic Control Without Hypoglycaemia
Safety Profile
- Very low risk of hypoglycaemia
- Does not cause weight gain
- Safe in elderly
- Renal dose adjustment required only for Sitagliptin
- First-line trusted drug
- Safe for long-term use
- Lesser GI disturbances
- Can be used up to eGFR > 30 ml/min/1.73 m²
- Safer alternative to sulfonylureas
- Minimizes glycemic variability
- Excellent tolerability
Guidelines & Global Recommendations
- DPP-4 inhibitors recommended as add-on therapy when Metformin alone fails
- Preferred in weight-neutral, hypoglycaemia-safe options
- Suitable for elderly, CKD stage 2–3 & CV-neutral risk patients
- Sitagliptin + Metformin recommended as Step-2 therapy
- Excellent for early dual therapy
- Effective in patients with high post-meal glucose
Sitasaur M 100/500
Sitagliptin Phosphate 100 mg & Metformin Hydrochloride 500 mg Tablets
Strong Control Without Hypoglycaemia
Sitagliptin
- Increases active incretin levels (GLP-1 & GIP)
- Enhances glucose-dependent insulin secretion
- Suppresses glucagon release
- Major effect on post-meal glucose control
Metformin
- ↓ Hepatic glucose production
- ↑ Peripheral insulin sensitivity
- ↑ Glucose uptake by muscles
- Improves fasting blood glucose
Clinical Benefits
- Strong HbA1c reduction (average ↓ 1.1–1.5%)
- Weight neutral – no weight gain unlike SU or insulin
- Low hypoglycaemia risk (glucose-dependent insulin response)
- Better post-prandial control via incretin enhancement
- Improved GI tolerance vs Metformin alone
- Ideal add-on therapy after Metformin failure
Empavion 25
Empagliflozin 25 mg Tablets
For Improving Glycemic & Metabolic Parameters
Indication
Type 2 Diabetes Mellitus
Modern Approach
- Targets renal glucose transport
- Provides superior glycemic control
- Improves overall metabolic profile
Mechanism of Action
- Reduces glucose reabsorption in kidneys
- Increases urinary glucose excretion
- Lowers fasting & postprandial glucose
Additional Benefits
- Supports weight reduction
- Helps control blood pressure
- Offers cardio-renal protection
Clinical Benefits
- Effective glycemic control with low hypoglycaemia risk
- Weight & blood pressure reduction benefits
- Improves cardiovascular & renal outcomes
- Ideal add-on or monotherapy in Type 2 Diabetes
Empavion-L 25/5
Empagliflozin 25 mg + Linagliptin 5 mg Tablets
Dual Advantage. Complete Control with Low Hypoglycaemia Risk
Mechanism of Action
- Dual mechanism provides durable glycaemic control
- SGLT2 inhibition (Empagliflozin) reduces renal glucose reabsorption
- DPP-4 inhibition (Linagliptin) enhances incretin effect
- Provides cardiovascular & renal protection
Safety, Tolerability & Advantages
- Low risk of hypoglycaemia
- Mild to moderate weight loss
- Safe in renal impairment down to eGFR 45 ml/min
- Once-daily convenient dosing
Clinical Evidence
- EMPA-REG OUTCOME: Empagliflozin reduced CV mortality by 38% & HF hospitalization by 35%
- CARMELINA: Linagliptin demonstrated cardiovascular & renal safety
Guidelines & Recommendations (2024–2025)
- ADA & EASD recommend SGLT2i + DPP-4i combination for patients uncontrolled on monotherapy
- Improves glycaemic control without increasing hypoglycaemia risk
- Effective across all stages of Type 2 Diabetes progression
Empavion M 12.5/500
Empagliflozin 12.5mg + Metformin 500mg Tablets
Trusted Duo for Diabetes Care... To enhance insulin Sensitivity & Promote Glucose Excretion
Indication
Diabetes Management (Type 2 Diabetes Mellitus)
Mechanism of Action
- Dual mechanism ensures strong glucose lowering
- Enhances insulin sensitivity
- Promotes glucose excretion
Safety & Tolerability
- Low risk of hypoglycemia
- Proven safety and tolerability
- Promotes modest weight loss
Clinical Evidence
- Significantly reduces CV death
- Reduces heart failure hospitalization
- Demonstrated sustained glycemic control
Clinical Benefits
- Cardioprotective and renoprotective proven benefits
- Preferred for cardioprotective profile (ADA & EASD 2024 Guidelines)
- Weight and BP benefits
- Complementary and durable benefits for renal risk patients
Rozarion-10
Rosuvastatin 10 mg Tablets
Strong LDL Reduction. Proven Heart Protection... In ACS Patients & Post PCI Patients
Indication
Dyslipidemia & Cardiovascular Risk Management
Mechanism of Action
- Blocks HMG-CoA reductase to lower cholesterol synthesis
- Increases LDL receptors to lower LDL-C
- Hydrophilic and hepatoselective with long half-life (~19 h)
Rozarion Advantages
- Superior potency at lower doses
- Better outcomes vs. atorvastatin
- Aligned with 2025 global guidelines
Latest Guideline Insights
- AHA/ACC/AACE 2025: Early, intensive & sustained LDL-C lowering
- NLA 2025: 'Lower for Longer' approach
- LDL-C goal: <55 mg/dL for very high-risk patients
Real-World Outcomes (Registry Data 2024)
- Reduced all-cause mortality by 26% vs. Atorvastatin
- Reduced MACE (Major Adverse Cardiovascular Events) by 29% vs. Atorvastatin
- JUPITER Trial: 44% reduction in major CV events in patients with elevated hs-CRP
Rozarion-20
Rosuvastatin Tablets I.P. 20 mg
Strong LDL Reduction. Proven Heart Protection... In ACS Patients & Post PCI Patients
Indication
Burden of Dyslipidemia & Cardiovascular Risk Management
Mechanism of Action
- Blocks HMG-CoA reductase to lower cholesterol synthesis
- Increases LDL receptors to lower LDL-C
- Hydrophilic, hepatoselective, long half-life (~19 h)
Rozarion Advantages
- Superior potency at lower doses
- Better outcomes vs. atorvastatin
- Aligned with 2025 global guidelines
JUPITER Trial Insights
- 44% reduction in major CV events
- 20% reduction in all-cause mortality
- Trial stopped early due to overwhelming benefit
Real-World Outcomes (Registry Data 2024)
- Rosuvastatin reduced all-cause mortality by 26% vs. Atorvastatin
- Reduced MACE (Major Adverse Cardiovascular Events) by 29% vs. Atorvastatin
- AHA/ACC/AACE 2025: Recommended for early, intensive & sustained LDL-C lowering
Rozarion-Gold 10
Rosuvastatin 10mg (IR), Clopidogrel 75mg (IR) & Aspirin 75mg (EC) Capsules
The Golden Shield for Heart Health... In the aggressive prevention in high risk cardiovascular profile
Indication
Post-ACS Management & Secondary Prevention of Cardiovascular Events
Triple Mechanism
- Rosuvastatin: Lowers LDL-C & stabilizes plaques
- Clopidogrel: Blocks P2Y12 & reduces platelet aggregation
- Aspirin: Inhibits COX-1 for anti-thrombotic effect
Comparative Efficacy
- Superior LDL-C reduction vs Atorvastatin combos
- Better hsCRP reduction for inflammation control
- Higher event prevention rate
Clinical Guidelines
- ACC/AHA 2023: Post-ACS intensive statin + DAPT recommended
- ESC 2024: FDCs improve adherence and outcomes
- Fits modern secondary-prevention guidance
Safety & Tolerability
- Rosuvastatin: Low myopathy risk at usual doses
- Antiplatelet combo: Balanced effect with monitored bleeding risk
- Comprehensive protection against lipids, clotting, and inflammation
Rozarion-Gold 20
Rosuvastatin 20mg (IR), Clopidogrel 75mg (IR) & Aspirin 75mg (EC) Capsules
The Golden Shield for Heart Health... In the aggressive prevention in high risk cardiovascular profile
Indication
Atherosclerosis management involving lipids, clotting, and inflammation
Triple Mechanism of Action
- Rosuvastatin: Lowers LDL-C and helps stabilize plaques
- Clopidogrel: Blocks P2Y12 and reduces platelet aggregation
- Aspirin: Inhibits COX-1 to lower thromboxane-driven clotting
Clinical Evidence
- JUPITER Trial: Rosuvastatin significantly reduces major CV events
- CURE Trial: Dual antiplatelet therapy reduces recurrent ischemic events
- ASCOT-LLA: Statins shown to improve outcomes in hypertension
Guideline Support
- ACC/AHA 2023: Post-ACS intensive statin + DAPT recommended
- ESC 2024: Fixed-Dose Combinations (FDCs) improve adherence
- Fits modern secondary-prevention guidance
Safety & Brand Summary
- Rosuvastatin offers low myopathy risk at usual doses
- Antiplatelet combo provides a balanced effect
- Superior efficacy in LDL-C and hsCRP reduction vs Atorvastatin combos
Rozarion-EZ
Rosuvastatin 20mg + Ezetimibe 10mg
Dual Action. Max Cholesterol Control... For management of dyslipidemia & hyper cholesterolemia
Indication
Hypercholesterolemia & Early aggressive lipid control to prevent major events
Dual Mechanism of Action
- Rosuvastatin: Increases cholesterol synthesis
- Ezetimibe: Increases cholesterol absorption
- Combo: LDL-C down up to ~65%
Brand Highlights
- Dual cholesterol blockade
- Statin + ezetimibe synergy
- Better LDL goal achievement
Latest Lipid Guidelines
- Target LDL <55 mg/dL for very high risk
- Add ezetimibe if statin not enough
- FDC (Fixed-Dose Combination) ensures better adherence
Clinical Evidence
- EXPLORER, GRAVITY & IMPROVE-IT trials show stronger LDL drop
- Fewer CV events & improved outcomes
- Synergistic effect for patients where statin monotherapy is insufficient
Ezevion-10
Ezetimibe 10mg Tablets
Add Power Beyond Statins... An adjunct to LDL therapy
Indication
Hypercholesterolemia management, especially when LDL goals are not met on statins alone
Mechanism of Action
- Blocks NPC1L1 in the intestine
- Inhibits cholesterol absorption
- Complements statins (liver synthesis)
Clinical Benefits
- Adds ~25% extra LDL reduction
- Lowers TC, ApoB, and non-HDL
- Well-tolerated and safe profile
Latest Lipid Guidelines
- Add ezetimibe if LDL goal not met on statins
- Early combo therapy for high-risk ASCVD
- Outcome benefits proven in multiple trials
Clinical Evidence – Key Trials
- IMPROVE-IT: Combo leads to fewer CV events (32.7% vs 34.7%)
- EASE: Combo results in +25% more LDL drop vs statin alone
- SHARP: Combo leads to 17% fewer major events in CKD patients
Esovion-40
Esomeprazole Magnesium Gastro-Resistant Tablets I.P. 40 mg
Rapid Relief. Reliable Healing... For treatment of gastroesophageal reflux disease (GERD)
Indication
GERD, Peptic ulcers, Heartburn, Regurgitation & Mucosal injury
Mechanism of Action
- Blocks the H+/K+-ATPase proton pump in parietal cells
- Provides strong & long-lasting acid suppression
- Works faster & more consistently than omeprazole
Clinical Evidence
- Achieves faster & higher healing rates in erosive esophagitis
- Provides rapid symptom relief within 1-3 days
- Superior mucosal healing & sustained control in chronic GERD
Guideline Endorsements
- ACG 2024: PPIs are first-line for GERD & peptic ulcers
- Esomeprazole preferred for stronger acid suppression
- Safe for long-term use with medical supervision
Safety, Tolerability & Brand Summary
- Well-tolerated with minimal adverse effects
- High healing rates & low relapse risk
- Rapid symptom relief enhances patient compliance
- Saurion Healthcare | Smart Gastrocare
Esovion-D
Esomeprazole 40 mg + Domperidone 30 mg Capsules
Dual Relief. Fast Action. Total Comfort... For acid suppression and motility improvement
Indication
GERD, Dyspepsia, Acid reflux with associated nausea
Mechanism of Action
- Esomeprazole: Blocks proton pump to strongly reduce acid
- Domperidone: Improves gastric emptying & esophageal motility
- Combo: Provides faster relief from acidity, bloating & nausea
Clinical Evidence
- Faster symptom relief compared to PPI alone
- Greater improvement in gastric motility
- Reduction in postprandial fullness
Dosing & Administration
- Contains Esomeprazole 40 mg + Domperidone 30 mg
- Taken once daily, 30 minutes before meals
- As advised by a clinician
GERD & Dyspepsia Management
- Combo helps when reflux is coupled with nausea or slow emptying
- Domperidone is better tolerated in this combination
- Enhanced patient satisfaction & compliance due to dual benefit
- Saurion Healthcare | Smart Gastrocare
Febusaur-40
Febuxostat Tablets 40 mg
Smart Uric Acid Control. Strong Joint Protection... In Uric Acid Lithiasis, Primary/Secondary Gout, Tophi & Joint Destruction
Indication
Gout & Hyperuricemia Management
Mechanism of Action
- Selective XO inhibitor
- Blocks both XO forms leading to less uric acid
- More selective than allopurinol
Clinical Evidence
- CONFIRMS: 40 mg hits uric-acid < 6 mg/dL better than allopurinol 300 mg
- CARES: CV safety similar to allopurinol
- Long-term therapy leads to fewer flares
Guidelines 2024-2025
- ACR 2024: Use urate-lowering therapy for recurrent gout
- Preferred if allopurinol intolerance or renal issues exist
- Target uric acid: < 6 mg/dL
Safety, Tolerability & Brand Summary
- Better renal safety profile than allopurinol
- Lower risk of hypersensitivity reactions
- Saurion Healthcare | Smart Uric Acid Management
Brivasaur-50
Brivaracetam Tablets IP 50 mg
Smart Seizure Control. Superior Tolerability... For improved Seizure control with better Tolerability
Indication
Management of Epilepsy (recurrent abnormal brain activity)
Mechanism of Action
- High-affinity SV2A binder
- 10x stronger SV2A binding vs levetiracetam
- Modulates neurotransmitter release to stabilize neurons
Clinical Evidence
- Trials show higher ≥50% seizure-reduction vs placebo
- Faster onset + fewer behavioral side effects than levetiracetam
- Effective in both focal and generalized seizures
Guidelines 2024–2025
- ILAE/AES 2024: Preferred add-on for focal seizures
- Ideal for patients intolerant to levetiracetam
- Suitable for monotherapy conversion due to better tolerability
Safety, Tolerability & Brand Summary
- Low behavioral and CNS side effects
- Minimal drug interactions
- Better adherence + improved cognition
- Saurion Healthcare | Smart Neurocare
CoQrion
Coenzyme Q10 100mg + L-Carnitine 500mg + Astaxanthin 8mg + Lycopene 2500mcg + Selenium 40mg + Zinc 12.5mg + Piperine 5mg Tablet
Straight for every cells, energy for every day... for management of oxidative stress & fatigue
Overview
Fatigue & Energy Deficit: Helps in low cell energy, oxidative stress, weak muscles, and poor mitochondria
Clinical Evidence
- CoQ10 + L-Carnitine: Better energy & cardiac support
- Astaxanthin + Lycopene: Strong antioxidant + anti-inflammatory action
- Supports endurance, recovery, and wellness
Nutraceutical Support
- Aligns with cardiometabolic mitochondrial support
- Helpful in fatigue and high oxidative load
- Supports overall heart vitality
Performance Benefits
- Significant improvement in cellular energy (ATP Production)
- Enhanced antioxidant status improvement
- Nutrient combo helps support cell energy
Safety, Tolerability & Brand Summary
- Safe, well-tolerated, and non-stimulant
- Supports cellular health, stamina, and natural energy
- CoQrion – Smart nutrition for active living
- Saurion Healthcare | Smart Cardio Wellness
Previon
Probiotics (Lactobacilli) Prebiotic Capsules
Balancing Gut. Boosting Health. Pre & Probiotic Formula... For better digestion & nutrient absorption
Gut Microbiome Overview
- Microbiome crucial for digestion & immunity
- Lifestyle/antibiotics disturb balance
- Previon restores gut harmony & boosts immunity
Mechanism of Action
- Pro + Prebiotics — better digestion, absorption, immunity
- Reduce bloating, constipation, gut inflammation
- Safe for continuous digestive & immune support
Clinical Evidence
- Improves gut diversity & restores balance
- Reduces IBS, bloating, and antibiotic-linked diarrhea
- Strengthens gut barrier and supports immune modulation
Guidelines 2024–2025
- WHO/WGO: Probiotics recommended for gut protection
- Daily use boosts digestion & immunity
- Previon uses guideline-aligned multi-strain formula
Safety, Tolerability & Brand Summary
- Clinically safe; Non-habit forming
- Supports gut flora & immune wellness
- Reduces discomfort; improves nutrient absorption
- Saurion Healthcare | Smart Digestive Care
Booston
Multivitamin & Multimineral Tablets
When energy fades, support matters... Daily support for daily demands..!
Indication
Fatigue, Weakness & Tiredness, Vitamin & Mineral deficiency, Low energy levels, Weak immunity
Mode of Action
- Vitamins & minerals support key metabolic & enzymatic functions
- Antioxidants help neutralize free radicals & reduce oxidative stress
- Enhances cellular energy production & immune response
- Taurine 500mg for energy & heart support
- Lycopene 5000mcg for powerful antioxidant protection
Clinical Benefits
- Improves energy levels & reduces fatigue
- Strengthens immunity & supports heart health
- Promotes eye health & overall vitality
Usage Guidelines
- One tablet daily or as directed by a healthcare professional
- Preferably taken after meals
- Regular use recommended for optimal benefits
Safety Profile & Brand Summary
- Helps bridge daily vitamin & mineral deficiencies
- Supports sustained energy, immunity & overall wellness
- Designed for individuals with active, demanding lifestyles
- Scientifically balanced formulation; Generally well tolerated
Nacfizz-600
N-Acetyl L-Cysteine Effervescent Tablet
Advanced Respiratory & Antioxidant Support... For Mucolytic Agent in Productive Cough & Respiratory Conditions
Why Effervescent NAC Is Superior?
- Dissolves completely — delivers NAC in readily absorbable form
- Faster onset of action compared to regular tablets/capsules
- No gastric irritation — ideal for sensitive patients
- Ensures accurate dosing with every use
- Better palatability improves patient adherence
Enhanced Mucolytic Effect
Effervescent NAC works faster to:
- Break disulfide bonds in thick, sticky mucus
- Improve airway clearance within hours
- Provide better relief from chest congestion
- Allow deeper and easier breathing
Safety & Usage Summary
- Powerful antioxidant that replenishes glutathione levels
- Supports lung health and detoxification
- Easy-to-take orange flavored effervescent form
- Saurion Healthcare | Smart Respiratory Care
MYORION B
Berberine Hydrochloride 98% 250 mg, Chromium 50 mcg, Myo Inositol 1.1 gm, Vitamin D3 600IU, L-Methylfolate 451 mcg
The Synergetic Solution for PCOS... For Menstrual Irregularities, Supports Pregnancy Planning
Why Myorion-B?
- Clinically superior ingredients for holistic hormonal support
- High Myo-Inositol dose (1.1 g) for better results
- Added Berberine for effective metabolic correction
- Includes L-Methylfolate – active folate for superior absorption
- Complete hormonal and metabolic support in a single tablet
Clinical Evidence
- Combination therapy improves insulin sensitivity & reduces androgens
- Supports fertility and regulates menstrual cycles
- Vitamin D3 improves insulin regulation & hormonal balance
Strong Reasons to Prescribe
- Evidence-backed ingredients used globally for PCOS management
- Improves insulin sensitivity, ovulation, and metabolic profile
- Simplified, single daily tablet for patient convenience
Safety, Tolerability & Brand Summary
- Generally well tolerated with minimal side effects
- Safe for long-term metabolic and hormonal support
- Holistic hormonal support, simplified..!
- Saurion Healthcare | Smart Women's Care
MERION B12 PFS
Mecobalamin 1500 mcg (Prefilled Syringe)
Revitalizing Nerves. Restoring Strength... For nerve support and recovery
Peripheral Neuropathy Overview
- Nerve damage can lead to numbness, tingling, and pain
- Commonly seen in diabetes, alcohol use, and vitamin deficiencies
- Mecobalamin helps early nerve recovery
Mechanism of Action
- Mecobalamin = active B12 for nerves
- Helps myelin repair + axon regeneration
- Improves nerve conduction & signaling
- Supports DNA/protein synthesis for nerve repair
Clinical Evidence
- Studies show Mecobalamin 1500 mcg IM increases nerve-conduction speed
- Effective in diabetic & alcoholic neuropathy for better sensory + motor function
- Shows stronger nerve-regeneration vs other B12 forms
Patient Benefits (PFS)
- Ultra-thin needle for minimal pain
- Gentle intramuscular administration
- Reduced injection-site irritation
- Smooth, comfortable patient experience
- Ideal for pain-sensitive & elderly patients
Neuropathy Management
- 2024 guidelines support mecobalamin for diabetic neuropathy
- Preferred because it's already in active coenzyme form
- Can be used alone or with other neurotropic agents
Safety, Tolerability & Brand Summary
- Generally well-tolerated with good safety profile
- Minimal significant drug interactions
- Supports nerve recovery and may reduce neuropathic pain
- Saurion Healthcare | Smart Neurocare
SAURGEST-10
Dydrogesterone 10 mg Tablets
Consistent Efficacy. Reliable Hormonal Control... The Prolific Progestin
Indication
For Luteal Phase Support in ART, Threatened Miscarriage, and Habitual Abortion
About Dydrogesterone
- Acts specifically on endometrial progesterone receptors without androgenic or estrogenic effects
- Provides consistent hormonal control for reproductive & menstrual health
Mechanism of Action
- Normalizes luteal function
- Promotes endometrial secretory activity
- Stabilizes the uterine lining & supports early pregnancy
Guidelines 2024–2025
- Recommended by FOGSI, ESHRE & ASRM for luteal phase & pregnancy support
Clinical Benefits
- Proven efficacy in maintaining hormonal stability
- Trusted for high-risk pregnancy management
Safety, Tolerability & Brand Summary
- Well-tolerated with a favorable safety profile for both mother and fetus
- Saurgest-10 – Consistent Hormonal Support
- Saurion Healthcare | Smart Women's Care
